Evotec SE (EVO) Research & Development (2009 - 2025)
Evotec SE (EVO) recorded Research & Development of -$11.44 million in the quarter ended Dec 31, 2025, compared with -$10.4 million a year earlier.
Powered by 
Analysis
Evotec SE (EVO) Research & Development (2009 - 2025) Analysis & Trends
For the year ended Dec 31, 2025, Evotec SE reported Research & Development of -$42.38 million.
- Across earlier years, Research & Development came in at -$55.04 million in the year ended Dec 31, 2024, -$74.13 million in the year ended Dec 31, 2023, -$80.78 million in the year ended Dec 31, 2022 and -$85.44 million in the year ended Dec 31, 2021.
- The figure for the quarter ended Dec 31, 2025 is the lowest quarterly Research & Development since the quarter ended Sep 30, 2024.
- Per Business Quant, the preceding three quarters came in at -$10.19 million (quarter ended Sep 30, 2025), -$9.29 million (quarter ended Jun 30, 2025) and -$11.32 million (quarter ended Mar 31, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.55 Bn | 36.39 Bn | 1.44 Bn | - |
| 2 | Medpace Holdings | 17.19 Bn | 15.25 Bn | 201.64 Mn | - |
| 3 | Charles River Laboratories International | 14.06 Bn | 13.30 Bn | 363.37 Mn | - |
| 4 | Icon | 13.44 Bn | 10.55 Bn | 479.29 Mn | - |
| 5 | Fortrea Holdings | 1.91 Bn | 1.29 Bn | 139.20 Mn | - |
| 6 | Ginkgo Bioworks Holdings | 665.78 Mn | -96.30 Mn | 18.44 Mn | 46.21 Mn |
| 7 | Evotec SE | 565.34 Mn | -1.01 Bn | - | - |
| 8 | Champions Oncology | 68.06 Mn | 43.71 Mn | 7.70 Mn | 2.34 Mn |
| 9 | MindWalk Holdings | 62.59 Mn | 26.81 Mn | 1.61 Mn | 921,603.43 |
| 10 | Natural Alternatives International | 10.67 Mn | -22.35 Mn | 383,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -11.44 Mn |
| Sep 30, 2025 | -10.19 Mn |
| Jun 30, 2025 | -9.29 Mn |
| Mar 31, 2025 | -11.32 Mn |
| Dec 31, 2024 | -10.40 Mn |
| Sep 30, 2024 | -13.04 Mn |
| Jun 30, 2024 | -14.11 Mn |
| Mar 31, 2024 | -17.64 Mn |
| Dec 31, 2023 | -21.69 Mn |
| Sep 30, 2023 | 19.05 Mn |
| Jun 30, 2023 | -20.13 Mn |
| Dec 31, 2022 | -134.63 Mn |
| Sep 30, 2022 | 18.63 Mn |
| Jun 30, 2022 | -19.98 Mn |
| Mar 31, 2022 | -20.33 Mn |
| Dec 31, 2021 | -143.77 Mn |
| Sep 30, 2021 | 21.27 Mn |
| Jun 30, 2021 | -20.44 Mn |
| Mar 31, 2021 | -22.27 Mn |
| Dec 31, 2020 | -131.18 Mn |
API Access
Evotec SE Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=EVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "EVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=EVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();